Crinetics Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an…

Biotechnology
US, San Diego [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of CRNX's Analysis
CIK: 1658247 CUSIP: 22663K107 ISIN: US22663K1079 LEI: - UEI: -
Secondary Listings
CRNX has no secondary listings inside our databases.